Colistin As A Good Monotherapy to Restrain the Pathogenicity of Acinetobacter Baumannii In Vivo and In Vitro. Baghdad Sci.J 2022, 19 (2), 0255. https://doi.org/10.21123/bsj.2022.19.2.0255.